TABLE VIII.A.5.d.
Study | Year | LOE | Study design | Study groups | Clinical endpoint | Conclusion |
---|---|---|---|---|---|---|
Shirlaw et al.1158 | 2017 | 1b | Double-blinded randomized crossover trial (n = 56) | 2 weeks on each therapy mode in random order 1. APAP 6–20 cm H2O 2. CPAP |
Usage hours and visual analog scale to measure symptoms of aerophagia | APAP reduces the symptoms of aerophagia while not affecting compliance compared with CPAP. |